Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05544019
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:25.941723+00:00
Published At
2026-02-13T00:00:00+00:00
Record Updated At
2026-02-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mature B-Cell Neoplasm", "Non Hodgkin Lymphoma", "DLBCL", "Waldenstrom Macroglobulinemia", "MALT Lymphoma", "Follicular Lymphoma", "Pediatric-Type Follicular Lymphoma", "IRF4 Gene Rearrangement", "EBV-Positive DLBCL, Nos", "Burkitt Lymphoma", "Plasmablastic Lymphoma", "High-grade B-cell Lymphoma", "Primary Cutaneous Follicle Center Lymphoma", "Primary Effusion Lymphoma", "Mantle Cell Lymphoma", "DLBCL Germinal Center B-Cell Type", "Primary Mediastinal Large B Cell Lymphoma", "T-Cell/Histiocyte Rich Lymphoma", "ALK-Positive Large B-Cell Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma", "Splenic Marginal Zone Lymphoma", "Chronic Lymphocytic Leukemia", "Nodal Marginal Zone Lymphoma", "HHV8-Positive DLBCL, Nos", "Lymphoplasmacytic Lymphoma", "Duodenal-Type Follicular Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-13"
protocolSection.identificationModule.nctId
"NCT05544019"
protocolSection.identificationModule.officialTitle
"A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mature B-Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • DLBCL (protocolSection.conditionsModule.conditions)
  • Waldenstrom Macroglobulinemia (protocolSection.conditionsModule.conditions)
  • MALT Lymphoma (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Pediatric-Type Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • IRF4 Gene Rearrangement (protocolSection.conditionsModule.conditions)
  • EBV-Positive DLBCL, Nos (protocolSection.conditionsModule.conditions)
  • Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
  • Plasmablastic Lymphoma (protocolSection.conditionsModule.conditions)
  • High-grade B-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous Follicle Center Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Effusion Lymphoma (protocolSection.conditionsModule.conditions)
  • Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • DLBCL Germinal Center B-Cell Type (protocolSection.conditionsModule.conditions)
  • Primary Mediastinal Large B Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • T-Cell/Histiocyte Rich Lymphoma (protocolSection.conditionsModule.conditions)
  • ALK-Positive Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Splenic Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Nodal Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • HHV8-Positive DLBCL, Nos (protocolSection.conditionsModule.conditions)
  • Lymphoplasmacytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Duodenal-Type Follicular Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.